Literature DB >> 12039894

Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 beta-lactamases.

Nancy D Hanson1, Ellen S Moland, Ashfaque Hossain, Stephen A Neville, Iain B Gosbell, Kenneth S Thomson.   

Abstract

Beta-lactam resistance in Salmonella isolates is increasing. This paper describes the combination of three different beta-lactamases, OXA-30, SHV-9 and CMY-7, expressed by an isolate of Salmonella enterica serotype Typhimurium. This is the first report of an isolate of Salmonella having both an extended-spectrum beta-lactamase and an AmpC beta-lactamase.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12039894     DOI： 10.1093/jac/dkf052

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  21 in total

1.  Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.

Authors:  Ellen Smith Moland; Jennifer A Black; Jason Ourada; Mark D Reisbig; Nancy D Hanson; Kenneth S Thomson
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

2.  Multiple outbreaks of nosocomial salmonellosis in Russia and Belarus caused by a single clone of Salmonella enterica serovar Typhimurium producing an extended-spectrum beta-lactamase.

Authors:  M Edelstein; M Pimkin; T Dmitrachenko; V Semenov; N Kozlova; D Gladin; A Baraniak; L Stratchounski
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  Detection of a bla(SHV) extended-spectrum {beta}-lactamase in Salmonella enterica serovar Newport MDR-AmpC.

Authors:  Shelley C Rankin; Jean M Whichard; Kevin Joyce; Lynn Stephens; Kathleen O'shea; Helen Aceto; Donald S Munro; Charles E Benson
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  First extended-spectrum-beta-lactamase (CTX-M-15)-producing Salmonella enterica serotype typhimurium isolate identified in Lebanon.

Authors:  C Moubareck; F Doucet-Populaire; M Hamze; Z Daoud; F-X Weill
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp.

Authors:  Ashfaque Hossain; M J Ferraro; R M Pino; R B Dew; E S Moland; T J Lockhart; K S Thomson; R V Goering; N D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

6.  Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan.

Authors:  Katsutoshi Yamasaki; Masaru Komatsu; Noriyuki Abe; Saori Fukuda; Yugo Miyamoto; Takeshi Higuchi; Tamotsu Ono; Hisaaki Nishio; Noriyuki Sueyoshi; Kaneyuki Kida; Kaori Satoh; Masahiro Toyokawa; Isao Nishi; Masako Sakamoto; Masahiro Akagi; Isako Nakai; Tomomi Kofuku; Tamaki Orita; Yasunao Wada; Takumi Jikimoto; Shohiro Kinoshita; Kazuaki Miyamoto; Itaru Hirai; Yoshimasa Yamamoto
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

7.  Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community.

Authors:  Nancy D Hanson; Ellen Smith Moland; S G Hong; Katie Propst; Deborah J Novak; Stephen J Cavalieri
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

8.  Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates.

Authors:  Johann D D Pitout; Deirdre L Church; Daniel B Gregson; Barbara L Chow; Melissa McCracken; Michael R Mulvey; Kevin B Laupland
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

9.  Characterization of the first extended-spectrum beta-lactamase-producing Salmonella isolate identified in Canada.

Authors:  Michael R Mulvey; Geoff Soule; David Boyd; Walter Demczuk; Rafiq Ahmed
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary.

Authors:  Johann D D Pitout; Daniel B Gregson; Deirdre L Church; Kevin B Laupland
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.